STE(STERIS plc) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-03-31 | FY 截至 2023-03-31 | FY 截至 2024-03-31 | FY 截至 2025-03-31 | FY 截至 2026-03-31 |
|---|---|---|---|---|---|
| 营业收入 | $4.22B | $4.54B | $5.14B | $5.46B | $5.94B |
| 毛利润 | $1.88B | $1.98B | $2.22B | $2.40B | $2.63B |
| 营业利润 | $477.81M | $791.10M | $836.10M | $866.60M | $1.10B |
| 净利润 | $243.89M | $107.03M | $378.20M | $614.60M | $782.30M |
| 经营现金流 | $684.81M | $756.95M | $973.30M | $1.15B | $1.34B |
| 自由现金流 | $397.25M | $394.98M | $613.00M | $778.00M | $972.40M |
| 摊薄每股收益 | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 |